SCHEMBL21099202

SCHEMBL21099202

c1ccc2[nH]c(-c3ccc4ncoc4c3)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.50
RAB9A P51151 4/20 0.50
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CASP3 P42574 2/20 0.49
SENP8 Q96LD8 2/20 0.49
SENP7 Q9BQF6 2/20 0.49
SENP6 Q9GZR1 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
DYRK1A Q13627 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
CYP19A1 P11511 1/20 0.46
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18880102 0.90 ESR1 (0.49) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL18671143 0.89 ESR1 (0.43) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL20251053 0.87 APP (0.42) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL21851203 0.87 DYRK1A (0.41) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL19200022 0.86 DYRK1A (0.38) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL23660807 0.82 RIPK1 (0.51) DYRK1A
SCHEMBL19287942 0.81 ESR1 (0.48) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL19425952 0.80 FOXO1 (0.44) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL23507947 0.77 DYRK1A (0.39) NPC1RAB9AKDM4EMAPTMEN1
SCHEMBL23871266 0.77 NPC1 (0.56) NPC1RAB9AKDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190177338-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177338-A1 CHEMICAL COMPOUNDS MKI67, CCNI, MCL1 NPC1 462/4885RAB9A 1639/4885KDM4E 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.